MedTrace Logo

Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients

NCT03089970 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2021-08-20

No results posted yet for this study

Summary

Respiratory virus infections cause a majority of asthma exacerbations in the fall to spring months. Current diagnostic platforms for respiratory viruses have limitations including cost, availability, and invasiveness. The use of noninvasive breath collection to analyze breath metabolites may be used to differentiate virus-infected asthmatics from other causes of acute asthma exacerbations.

Conditions

  • Upper Respiratory Tract Infections, Asthma, Exhaled Breath

Interventions

DIAGNOSTIC_TEST

Exhaled breath condensate collection

Breath from humans is cooled, condensed, and collected

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Michael Schivo, MD, MAS · University of California, Davis

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2020-03-10
Completion
2020-09-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03089970 on ClinicalTrials.gov